Partners Capital Investment Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$457K Sell
3,581
-3,353
-48% -$419K 0.02% 132
2025
Q4
$845K Hold
6,934
0.03% 113
2025
Q3
$695K Hold
6,934
0.03% 120
2025
Q2
$575K Sell
6,934
-6,934
-50% -$553K 0.02% 123
2025
Q1
$1.12M Buy
13,868
+6,934
+100% +$620K 0.02% 136
2024
Q4
$624K Sell
6,934
-6,934
-50% -$672K 0.02% 112
2024
Q3
$1.37M Hold
13,868
0.02% 133
2024
Q2
$1.29M Buy
13,868
+6,934
+100% +$622K 0.02% 136
2024
Q1
$658K Sell
6,934
-8,099
-54% -$752K 0.02% 126
2023
Q4
$1.34M Buy
15,033
+2
+0% +$149 0.03% 134
2023
Q3
$1.1M Buy
15,031
+6,950
+86% +$555K 0.03% 139
2023
Q2
$672K Buy
8,081
+4,728
+141% +$395K 0.01% 157
2023
Q1
$256K Hold
3,353
0.01% 121
2022
Q4
$278K Hold
3,353
0.01% 121
2022
Q3
$266K Buy
+3,353
New +$283K 0.02% 120

Other funds holding XBI